Mostox Powder (Each 1000g contains Acetic Acid 20g/Propionic Acid 20g/Butyric Acid 10g/Hydrated Sodium Calcium Alumino Silicate 40g/Activated Charcoal 10g/Phyllantus Emblica 10g/Mannan Oligosaccharide 5g/Bacillus Subtilis 1*10 +9cfu)

Indications

• Infections (topical treatment)
• Wound care (as an antiseptic)
• Ear infections (as an ear drop solution)
• Acid-base balance in metabolic acidosis

Dosage

Children: Refer to established guidelines as dosage may vary based on the formulation and indication.

Adults: Refer to established guidelines as dosage may vary based on the formulation and indication.

Mechanism of action

Acetic acid exerts its effects primarily through its ability to lower pH levels, creating an acidic environment which is inhospitable to many pathogens. It can disrupt the integrity of microbial cell membranes, leading to cell lysis and death. Additionally, acetic acid can promote the healing of wounds and enhance the absorption of certain medications when used as a solvent.

Pharmacodynamics

The pharmacodynamics of acetic acid involve its interaction with biological systems, leading to changes in cellular functions. Its acidic nature helps in the denaturation of proteins and disruption of microbial metabolism. This contributes to its antibacterial and antifungal activities, making it effective against a range of pathogens.

Pharmacokinetics

Acetic acid is rapidly absorbed in the gastrointestinal tract when ingested. It is metabolized primarily in the liver, converting to acetyl CoA and subsequently entering various metabolic pathways including the citric acid cycle. The elimination half-life varies but is generally short, with excretion occurring mainly via urine. When applied topically, absorption is minimal, and local effects are predominant.

Pregnancy

The safety of acetic acid during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

There is no specific information available regarding the use of acetic acid during breastfeeding. Caution is advised.

Storage

Store in a cool, dry place away from direct sunlight. Keep tightly closed in a well-ventilated area.

Indications

• Acute poisoning
• Drug overdose
• Gastrointestinal decontamination

Dosage

Children: Refer to specific pediatric dosing recommendations based on the child's weight and the clinical situation.

Adults: Refer to specific guidelines depending on the type of poisoning and the clinical scenario.

Mechanism of action

Activated charcoal works through a process called adsorption, where toxins and drugs adhere to the surface of the charcoal particles due to electrostatic attractions and Van der Waals forces. This prevents the absorption of these substances in the gastrointestinal tract, allowing them to be excreted from the body.

Pharmacodynamics

The pharmacodynamic effects of activated charcoal are related to its ability to bind a wide range of substances. The efficacy of activated charcoal varies depending on the type and amount of the toxin or drug ingested, as well as the time elapsed since ingestion. Generally, activated charcoal is most effective when administered within one hour of ingestion of a toxic substance.

Pharmacokinetics

Activated charcoal is not absorbed by the gastrointestinal tract; instead, it remains in the gut, where it binds to ingested substances and promotes their elimination via feces. Its effects are dose-dependent, and it is typically administered as a single dose, although multiple doses may be considered in certain cases of severe poisoning.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Aspiration pneumonia (if inhaled)
• Electrolyte imbalances

Precautions

• Use with caution in patients with gastrointestinal obstruction
• Monitor for potential aspiration in patients with reduced consciousness
• Consider electrolyte levels in patients with significant diarrhea or vomiting

Pregnancy

Activated charcoal is generally considered safe for use in pregnancy, but consult a healthcare professional before use.

Breast-feeding

Activated charcoal is excreted in breast milk, use with caution and consult a healthcare professional.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Activated charcoal powder
• Activated charcoal capsules
• Activated charcoal tablets

Indications

• Peptic ulcer disease
• Gastroesophageal reflux disease (GERD)
• Dyspepsia (indigestion)
• Acid-related disorders

Dosage

Children: Refer to the BNF for Children for appropriate dosing recommendations, which may differ based on the child's age, weight, and clinical condition.

Adults: Refer to the BNF for specific dosing recommendations, as doses can vary based on the formulation and individual patient needs.

Mechanism of action

Aluminum hydroxide acts as a weak base that reacts with hydrochloric acid in the stomach to form aluminum chloride and water. This reaction decreases gastric acidity, leading to increased gastric pH. By neutralizing stomach acid, it alleviates symptoms of heartburn and discomfort associated with hyperacidity.

Pharmacodynamics

The pharmacodynamic effects of aluminum hydroxide include the reduction of gastric acidity and the formation of a protective barrier in the gastrointestinal tract. The compound has a relatively slow onset of action, with effects generally observed within 20 to 60 minutes after administration, depending on the formulation. It can also bind to phosphate in the gastrointestinal tract, potentially leading to decreased absorption of dietary phosphate.

Pharmacokinetics

Aluminum hydroxide is poorly absorbed from the gastrointestinal tract, with less than 1% of the ingested dose being absorbed. The majority of the aluminum remains in the gastrointestinal lumen, where it exerts its antacid effect. Any absorbed aluminum is primarily excreted by the kidneys. The presence of food can affect the absorption and effectiveness of aluminum hydroxide, and it is important to consider renal function in patients using this medication, particularly in those with compromised kidney function.

Adverse effects

• Gastrointestinal irritation
• Constipation
• Nausea
• Vomiting

Interactions

• May reduce the absorption of other drugs due to its binding properties
• Antacids may interfere with the efficacy of certain medications

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of gastrointestinal obstruction or constipation

Pregnancy

Aluminum compounds should be used during pregnancy only if clearly needed, as safety has not been established.

Breast-feeding

Aluminum can be excreted in breast milk; caution is advised when using during lactation.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Aluminum hydroxide gel
• Aluminum carbonate
• Aluminum phosphate

Indications

• Bladder cancer
• Tuberculosis vaccination

Dosage

Children: Refer to the BNF for Children for appropriate dosing based on indication.

Adults: Refer to specific guidelines based on indication. For bladder cancer, a common regimen is instillation once a week for six weeks.

Mechanism of action

BCG works by stimulating the immune system, particularly through the activation of T-cells and macrophages. It enhances the immune response against tumor cells and Mycobacterium tuberculosis, promoting the release of cytokines and other immune mediators that contribute to the destruction of cancerous cells and pathogens.

Pharmacodynamics

The pharmacodynamics of BCG involve the induction of a robust immune response characterized by the activation of both innate and adaptive immunity. This includes the proliferation of T-lymphocytes and the production of cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukins, leading to increased immune surveillance and anti-tumor activity. The effectiveness of BCG is influenced by factors such as the host's immune status and the presence of any concurrent infections.

Pharmacokinetics

BCG is administered locally, and its pharmacokinetics are determined by the route of administration. After intravesical administration, BCG remains in the bladder and exerts its effects locally, with minimal systemic absorption. The half-life and clearance of BCG can vary based on the patient's immune response and presence of any concurrent conditions.

Interactions

• normal immunoglobulin + bacillus calmette-gurin vaccine: Unknown (decreases efficacy)

Pregnancy

Bacillus Calmette-Guérin (BCG) vaccine can be administered during pregnancy if the potential benefit outweighs the potential risk.

Breast-feeding

BCG vaccine may be administered during breastfeeding; however, caution is advised.

Storage

Store at 2-8 degrees Celsius. Do not freeze.

Formulations

• Bacillus Calmette-Guérin vaccine

Indications

• Inflammatory bowel disease (IBD)
• Ulcerative colitis
• Crohn's disease
• Irritable bowel syndrome (IBS)
• Metabolic syndrome
• Gut health maintenance

Dosage

Children: Dosage must be determined based on individual clinical scenarios and should be guided by healthcare practitioners familiar with paediatric care.

Adults: Dosage varies widely depending on the formulation and clinical indication. Refer to specific product guidelines and consult healthcare professionals for recommendations.

Mechanism of action

Butyric acid exerts its effects primarily through its role as a histone deacetylase inhibitor, which influences gene expression and promotes the differentiation of gut epithelial cells. It also serves as an energy source for colonocytes and has anti-inflammatory properties by modulating the immune response in the gut.

Pharmacodynamics

Butyric acid is known to enhance intestinal barrier function, promote mucosal healing, and exert anti-inflammatory effects. It helps to increase the production of mucins and promotes the growth of beneficial gut bacteria, contributing to overall gut health. Additionally, it has effects on lipid metabolism and may play a role in regulating appetite and metabolism.

Pharmacokinetics

Butyric acid is rapidly absorbed in the gastrointestinal tract and is extensively metabolized in the liver. Its bioavailability can vary based on dietary intake and the presence of gut microbiota. It is also known to be taken up by colonocytes, where it is used as a primary energy source. The elimination of butyric acid occurs primarily through metabolic pathways, although specific details on half-life and clearance rates in humans are limited.

Adverse effects

• Abdominal pain
• Diarrhea
• Nausea
• Vomiting
• Flatulence

Precautions

• Use with caution in patients with gastrointestinal disorders
• Monitor for gastrointestinal side effects
• Not recommended in patients with known allergies to butyric acid or its derivatives

Pregnancy

Safety during pregnancy has not been established. Use with caution and only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Consult a healthcare provider before use during breastfeeding, as it is not known whether butyric acid is excreted in human milk.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral capsules
• Powder for oral solution

Indications

• Acute poisoning
• Drug overdose
• Gastrointestinal decontamination
• Treatment of certain types of toxin ingestion

Dosage

Children: For children over 1 year of age, the recommended dosage of activated charcoal is 1 gram per kilogram of body weight, up to a maximum of 50 grams. For children under 1 year, consult the BNF for Children for specific dosing guidance.

Adults: The usual adult dosage for activated charcoal in the treatment of poisoning is 50 to 100 grams, administered orally or via a nasogastric tube. Repeat doses may be given in certain cases, depending on the toxin involved.

Mechanism of action

Activated charcoal works primarily by adsorbing toxins and drugs in the gastrointestinal tract, reducing their systemic absorption. The extensive surface area and porous structure of activated charcoal allow it to bind various substances through van der Waals forces and hydrogen bonding. This binding action helps to prevent the absorption of harmful substances into the bloodstream, facilitating their elimination from the body.

Pharmacodynamics

The efficacy of activated charcoal is related to its ability to adsorb a wide range of substances, including many pharmaceuticals and poisons. The effectiveness can vary depending on the specific substance, the timing of administration, and the dose of activated charcoal. It is generally most effective when administered soon after ingestion of the toxin.

Pharmacokinetics

Activated charcoal is not absorbed systemically; it acts locally within the gastrointestinal tract. After administration, it passes through the gastrointestinal system and is eventually excreted in the feces. The adsorption capacity of activated charcoal is influenced by factors such as the surface area, particle size, and the nature of the toxin to which it is exposed.

Contra-indications

• Intestinal obstruction
• Gastrointestinal perforation
• Severe constipation

Adverse effects

• Gastrointestinal disturbances such as nausea and vomiting
• Constipation
• Black stools
• Aspiration pneumonia if inhaled

Interactions

• May reduce the absorption of certain medications, including anticoagulants, anticonvulsants, and others
• Should not be given simultaneously with other oral medications

Precautions

• Use with caution in patients with a history of gastrointestinal disorders
• Ensure airway protection in unconscious or compromised patients to prevent aspiration
• Monitor for potential electrolyte imbalances

Pregnancy

Charcoal is generally considered safe during pregnancy, but should only be used when necessary and under medical supervision.

Breast-feeding

Charcoal is unlikely to adversely affect a nursing infant, but should be used with caution.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Activated charcoal tablets
• Activated charcoal powder
• Activated charcoal suspension

Indications

• Antioxidant support
• Enhancement of immune function
• Skin health improvement
• Digestive health support
• Metabolic syndrome management
• Hepatoprotective therapy

Dosage

Children: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The active compounds in emblica, particularly emblicanin A and B, have been shown to exhibit antioxidant activity by scavenging free radicals and reducing oxidative stress. This action helps protect cells from damage, particularly in the liver and other organs. Additionally, emblica may modulate various biochemical pathways, including the enhancement of glutathione levels, which is critical for detoxification and cellular protection.

Pharmacodynamics

Emblica demonstrates a range of pharmacological effects, including anti-inflammatory, antimicrobial, and hepatoprotective actions. The fruit has been found to improve lipid profiles and glucose metabolism, making it potentially beneficial for metabolic syndrome and diabetes management. Furthermore, its immunomodulatory properties can enhance the immune response, contributing to overall health.

Pharmacokinetics

The pharmacokinetics of emblica are not extensively studied; however, its active compounds are believed to be rapidly absorbed in the gastrointestinal tract. The bioavailability and half-life of these compounds can be influenced by factors such as formulation and concurrent food intake. Metabolism primarily occurs in the liver, and excretion is likely via both renal and biliary pathways.

Adverse effects

• Gastrointestinal upset
• Diarrhea
• Nausea
• Vomiting
• Allergic reactions

Interactions

• May interact with anticoagulants, enhancing their effects
• Possible antagonism with certain chemotherapy agents

Precautions

• Use with caution in individuals with allergies to plants in the Euphorbiaceae family
• Monitor blood sugar levels in diabetic patients

Pregnancy

Limited human data available; use only if clearly needed and benefits outweigh risks.

Breast-feeding

Limited data available; consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powdered extract
• Capsules
• Tablets
• Liquid extract

Indications

• Dehydration
• Heat-related illnesses
• Kidney function support
• Physical performance enhancement
• Maintenance of electrolyte balance

Dosage

Children: Dosage varies by age and weight. Pediatric hydration needs should be determined based on clinical assessment and specific guidelines for the child's condition.

Adults: Dosage depends on the specific hydration needs and underlying conditions. Generally, individuals should consume adequate fluids to maintain normal hydration status.

Mechanism of action

Hydration works by maintaining fluid balance in the body, which is essential for processes such as nutrient transport, temperature regulation, and waste elimination. It helps in the dissolution and transport of drugs within the bloodstream, facilitating their distribution and absorption. Water is a critical solvent that enables biochemical reactions necessary for drug metabolism.

Pharmacodynamics

Hydration influences drug pharmacodynamics by affecting drug solubility and availability at the target sites. Adequate hydration can enhance the efficacy of medications, particularly those that require dissolution in bodily fluids for absorption. Conversely, dehydration can lead to increased drug concentrations, potentially resulting in toxicity or adverse effects.

Pharmacokinetics

The pharmacokinetics of drugs can be significantly affected by hydration status. In a well-hydrated individual, the absorption, distribution, metabolism, and excretion of drugs can occur more efficiently. Dehydration may lead to altered pharmacokinetics, potentially increasing the half-life of certain medications and requiring careful monitoring of drug dosing.

Adverse effects

• Fluid overload
• Electrolyte imbalance
• Hypotension
• Headache
• Nausea
• Vomiting

Precautions

• Use with caution in patients with renal impairment
• Monitor electrolytes during prolonged use
• Consider risk of fluid overload in patients with heart failure

Pregnancy

Hydration is generally safe during pregnancy, but excessive fluid intake should be avoided.

Breast-feeding

Adequate hydration is important during breastfeeding, but care should be taken to maintain electrolyte balance.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral rehydration solutions
• Intravenous fluids
• Electrolyte replacement solutions

Indications

• Immunomodulation
• Support in infections
• Potential use in cancer therapy

Mechanism of action

Mannan exerts its effects primarily through modulation of the immune system. It interacts with specific receptors on immune cells, such as macrophages and dendritic cells, leading to activation of these cells and enhancement of cytokine production. This action can stimulate both innate and adaptive immunity, contributing to the body's defense against pathogens.

Pharmacodynamics

The pharmacodynamics of mannan involve its ability to stimulate immune responses, including the activation of complement pathways and enhancement of phagocytosis by immune cells. Its immunomodulatory properties can lead to increased production of pro-inflammatory cytokines, which play a crucial role in the body's response to infections and the development of immune tolerance in various diseases.

Pharmacokinetics

Mannan is generally not absorbed in the gastrointestinal tract due to its complex polysaccharide structure. Instead, it may exert local effects in the gut, and its immunomodulatory effects are thought to be mediated through its interaction with gut-associated lymphoid tissue. The exact pharmacokinetic profile, including metabolism and excretion, is not well-documented, necessitating further research to fully understand its behavior in the body.

Pregnancy

Safety in pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Safety during breastfeeding has not been established. Caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Prebiotic supplementation
• Support for digestive health
• Enhancement of gut microbiota
• Improvement of bowel regularity
• Potential immune modulation

Dosage

Children: Refer to relevant clinical guidelines and individual products for dosing information, as specific dosing can vary based on the type of oligosaccharide and

Adults: Refer to relevant clinical guidelines and individual products for dosing information, as specific dosing can vary based on the type of oligosaccharide and the intended use.

Mechanism of action

Oligosaccharides act primarily by serving as substrates for beneficial gut bacteria, promoting their growth and activity. This fermentation process leads to the production of short-chain fatty acids (SCFAs), which have various health benefits, including anti-inflammatory effects and improved gut barrier function. Certain oligosaccharides may also modulate immune responses and influence the absorption of minerals.

Pharmacodynamics

The pharmacodynamics of oligosaccharides relate to their fermentation in the colon, where they are metabolized by gut microbiota. This fermentation process results in the production of SCFAs, such as acetate, propionate, and butyrate, which can influence gut motility, enhance nutrient absorption, and provide energy to colonic epithelial cells. Additionally, oligosaccharides can modulate immune functions by influencing the activity of immune cells and cytokine production.

Pharmacokinetics

Oligosaccharides are generally not absorbed in the upper gastrointestinal tract; instead, they reach the colon intact, where they are fermented by the gut microbiota. The absorption of any resultant metabolites, such as SCFAs, occurs in the colon. The time to fermentation can vary based on the type of oligosaccharide and individual gut microbiota composition. Due to their low digestibility, they typically have a low caloric value.

Adverse effects

• Gastrointestinal discomfort
• Bloating
• Flatulence
• Diarrhea

Precautions

• Individuals with known allergies to oligosaccharides should avoid use.
• Use with caution in patients with gastrointestinal disorders.

Pregnancy

Oligosaccharides are generally considered safe during pregnancy, but it is advisable to consult a healthcare provider before use.

Breast-feeding

Oligosaccharides are typically safe while breastfeeding, as they are naturally occurring in breast milk and may promote gut health in infants.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Powder
• Capsules
• Tablets

Indications

• Hepatitis
• Liver disease
• Kidney stones
• Diabetes
• Antiviral therapy

Dosage

Children: Refer to specific herbal preparation guidelines for dosing in children, as specific doses of Phyllanthus are not standardized.

Adults: Refer to specific herbal preparation guidelines for dosing, as specific doses of Phyllanthus are not standardized.

Mechanism of action

Phyllanthus species contain several bioactive compounds, including flavonoids, alkaloids, and tannins, which contribute to their pharmacological effects. The mechanism of action involves the modulation of various biochemical pathways, including inhibition of viral replication, antioxidant activity, and the enhancement of liver function. Specific compounds like lignans have been shown to interfere with viral entry into cells and promote the elimination of toxins in the liver.

Pharmacodynamics

The pharmacodynamics of Phyllanthus involves its ability to interact with multiple biological targets. It exhibits hepatoprotective effects by reducing oxidative stress and preventing liver cell damage. Additionally, it has demonstrated antiviral activity against viruses such as hepatitis B and C, potentially by inhibiting viral replication and modulating immune responses. The anti-inflammatory properties of Phyllanthus may also contribute to its therapeutic effects.

Pharmacokinetics

The pharmacokinetics of Phyllanthus is not well-characterized, as it varies significantly among species and is influenced by the preparation method (e.g., extract, tincture). However, compounds from Phyllanthus are generally absorbed in the gastrointestinal tract, with bioavailability affected by formulation. Metabolism and excretion pathways are not fully elucidated, but they may involve hepatic and renal processes, similar to other phytochemicals.

Adverse effects

• Gastrointestinal disturbances
• Allergic reactions
• Hypoglycemia

Interactions

• May interact with antidiabetic medications, potentially enhancing their effects
• Possible interaction with anticoagulants, increasing bleeding risk

Precautions

• Use with caution in patients with diabetes
• Monitor blood sugar levels in patients taking antidiabetic medications
• Consult a healthcare provider before use in pregnant or breastfeeding individuals

Pregnancy

Limited data available. Consult a healthcare provider before use during pregnancy.

Breast-feeding

Limited data available. Consult a healthcare provider before use while breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Powder
• Capsule
• Extract
• Tea

Indications

• Pain relief
• Anti-inflammatory treatment
• Management of osteoarthritis
• Management of rheumatoid arthritis
• Treatment of dysmenorrhea
• Postoperative pain management

Dosage

Children: Refer to specific propionic acid derivative product monographs for paediatric dosing as it varies by formulation and condition treated.

Adults: Refer to specific propionic acid derivative product monographs for adult dosing as it varies by formulation and condition treated.

Mechanism of action

Propionic acid and its derivatives exert their effects primarily through the inhibition of cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins. This results in reduced inflammation, pain, and fever. By blocking COX-1 and COX-2 pathways, propionic compounds modulate the inflammatory response and provide analgesic effects.

Pharmacodynamics

Propionic compounds have a rapid onset of action, with effects noticeable within 30 minutes to an hour after administration. The anti-inflammatory effects are dose-dependent, and the duration of action typically lasts for several hours. The analgesic properties are also evident in acute and chronic pain management, providing relief from conditions such as arthritis, menstrual pain, and musculoskeletal disorders.

Pharmacokinetics

After oral administration, propionic acid is rapidly absorbed from the gastrointestinal tract. It is primarily metabolized in the liver, undergoing glucuronidation and oxidation. The elimination half-life of propionic derivatives varies but generally ranges from 1 to 4 hours. These substances are excreted primarily through urine, with a small fraction eliminated in feces. Due to their short half-lives, multiple dosing may be required to maintain therapeutic levels.

Contra-indications

• Hypersensitivity to propionic acid or its derivatives
• Active peptic ulcer disease
• Severe renal impairment

Adverse effects

• Gastrointestinal disturbances (nausea, vomiting, diarrhea)
• Dizziness
• Headache
• Rash
• Tinnitus
• Hepatotoxicity (rare)

Interactions

• Increased risk of gastrointestinal bleeding with NSAIDs
• Inhibition of renal excretion of certain drugs (e.g., lithium)
• Potential additive effects with other central nervous system depressants

Precautions

• Use with caution in patients with renal or hepatic impairment
• Monitor for signs of gastrointestinal bleeding in long-term use
• Caution in patients with asthma, as propionic acid derivatives may exacerbate symptoms

Pregnancy

Use in pregnancy only if clearly needed. Animal studies have shown adverse effects. There is limited data on human pregnancy.

Breast-feeding

Use with caution while breastfeeding. Propionic acid and its derivatives may pass into breast milk.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Oral tablets
• Oral suspension
• Topical formulations (creams, gels)

Indications

• Diarrhea
• Gastrointestinal infections
• Toxin elimination

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines as they are dependent on the formulation and condition being treated.

Adults: Refer to the BNF for specific dosing guidelines as they are dependent on the formulation and condition being treated.

Mechanism of action

Silicates function by adsorbing toxins and pathogens in the gastrointestinal tract, thereby reducing their absorption into the systemic circulation. This mechanism is particularly beneficial in conditions such as diarrhea or gastrointestinal infections, where the reduction of harmful substances can help alleviate symptoms.

Pharmacodynamics

The pharmacodynamics of silicates are characterized by their ability to bind with various substances in the gut, including toxins, bacteria, and other pathogens. This binding helps in reducing the irritative effects of these substances on the intestinal lining and can assist in normalizing bowel function.

Pharmacokinetics

Silicates are generally not absorbed systemically after oral administration. They act locally within the gastrointestinal tract, where they exert their effects. Due to their physical properties, they can remain in the gut for prolonged periods, enhancing their efficacy in adsorbing harmful agents.

Pregnancy

There is limited data on the use of silicates during pregnancy. It is advisable to avoid use unless clearly needed.

Breast-feeding

Silicates are not known to be excreted in human milk. Caution is advised when using.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Probiotic supplementation
• Support for gastrointestinal health
• Management of diarrhea, including antibiotic-associated diarrhea
• Enhancement of immune function
• Prevention of gastrointestinal infections

Dosage

Children: Refer to specific product guidelines as dosages can vary based on formulation and indication.

Adults: Refer to specific product guidelines as dosages can vary based on formulation and indication.

Mechanism of action

Bacillus subtilis exerts its effects primarily through the production of enzymes and antimicrobial substances that inhibit pathogenic bacteria. It enhances gut health by promoting the growth of beneficial bacteria, improving digestion, and modulating immune responses. Additionally, it has been shown to stimulate the production of short-chain fatty acids, which are beneficial for colon health and can help reduce inflammation.

Pharmacodynamics

The pharmacodynamic properties of Bacillus subtilis are linked to its probiotic effects. It competes with pathogenic organisms for nutrients and adhesion sites in the gut, thereby reducing the risk of infections. Furthermore, it can enhance the intestinal barrier function and stimulate the mucosal immune system, which plays a crucial role in maintaining gut homeostasis.

Pharmacokinetics

Bacillus subtilis is characterized by its ability to form resilient spores that can survive gastric acid and bile salts, allowing it to reach the intestines intact. Once in the gut, the spores germinate into vegetative cells, where they can exert their beneficial effects. The duration of action may vary based on individual gut microbiota composition and dietary factors, but generally, the effects can be observed within days to weeks of regular administration.

Pregnancy

Subtilis is generally considered safe during pregnancy, but it is advisable to consult a healthcare provider before use.

Breast-feeding

Subtilis is typically regarded as safe during breastfeeding, yet it is recommended to seek advice from a healthcare professional.

Storage

Store in a cool, dry place. Protect from light and moisture. Keep out of reach of children.